Introduction: In patients receiving deep brain stimulation (DBS) therapy, the longevity of the implanted pulse generator (IPG) is influenced by multiple factors, including patient diagnosis, therapeutic target, neurostimulator type, number of implanted leads, and stimulation settings. Recent advancements in DBS technology include longer-lived batteries, both standard and rechargeable. This study assessed the estimated IPG longevity of Medtronic, Inc., Percept™ PC neurostimulator in Parkinson’s disease (PD) and explores factors associated with IPG lifespan. Methods: Retrospective analysis of Percept™ devices in 31 PD patients who underwent bilateral DBS targeting either the internal globus pallidus or the subthalamic nucleus (STN). The analysis included demographics, clinical information, stimulation settings, lead locations, and total effective energy delivered (TEED). Results: The median IPG longevity was 75.9 months (51.6–92.3). Among stimulation parameters, frequency demonstrated the strongest inverse correlation with longevity (r = −0.49, p < 0.01), followed by pulse width (r = −0.39, p < 0.01), TEED (r = −0.35, p < 0.01), current amplitude (r = −0.33, p < 0.01), and voltage (r = −0.25, p = 0.04), regardless of laterality. In STN-targeted patients, a significant association was observed between the Z-coordinate of the right lead and the presence of side effects (p = 0.04). Monopolar stimulation on the dominant side showed significantly longer IPG longevity compared to bipolar stimulation (80.6 vs. 49.6 months, p = 0.01). Conclusion: Significant negative correlations were observed between longevity and various stimulation parameters regardless of laterality. Monopolar stimulation on the dominant side was associated with increased longevity.

1.
van Riesen
C
,
Tsironis
G
,
Gruber
D
,
Klostermann
F
,
Krause
P
,
Schneider
GH
, et al
.
Disease-specific longevity of impulse generators in deep brain stimulation and review of the literature
.
J Neural Transm
.
2016
;
123
(
6
):
621
30
.
2.
Fisher
B
,
Kausar
J
,
Garratt
H
,
Hodson
J
,
White
A
,
Ughratdar
I
, et al
.
Battery longevity comparison of two commonly available dual channel implantable pulse generators used for subthalamic nucleus stimulation in Parkinson’s disease
.
Stereotact Funct Neurosurg
.
2018
;
96
(
3
):
151
6
.
3.
Saad
M
,
Morris
R
,
Rudwick
C
.
206 longevity of deep brain stimulation batteries at a tertiary neurosurgical centre
.
Br J Surg
.
2022
;
109
(
Suppl_1
):
znac039
127
.
4.
De Schlichting
E
,
Coll
G
,
Zaldivar-Jolissaint
JF
,
Coste
J
,
Marques
AR
,
Mulliez
A
, et al
.
Pulse generator battery life in deep brain stimulation: out with the old… in with the less durable
.
Acta Neurochir
.
2019
;
161
(
10
):
2043
6
.
5.
Sarica
C
,
Iorio-Morin
C
,
Aguirre-Padilla
DH
,
Najjar
A
,
Paff
M
,
Fomenko
A
, et al
.
Implantable pulse generators for deep brain stimulation: challenges, complications, and strategies for practicality and longevity
.
Front Hum Neurosci
.
2021
;
15
:
708481
.
6.
Fakhar
K
,
Hastings
E
,
Butson
CR
,
Foote
KD
,
Zeilman
P
,
Okun
MS
.
Management of deep brain stimulator battery failure: battery estimators, charge density, and importance of clinical symptoms
.
PLoS One
.
2013
;
8
(
3
):
e58665
.
7.
Qiu
X
,
Peng
T
,
Lin
Z
,
Zhu
K
,
Wang
Y
,
Sun
B
, et al
.
Fixed-life or rechargeable battery for deep brain stimulation: preference and satisfaction in Chinese patients with Parkinson’s disease
.
Front Neurol
.
2021
;
12
:
668322
.
8.
Paff
M
,
Loh
A
,
Sarica
C
,
Lozano
AM
,
Fasano
A
.
Update on current technologies for deep brain stimulation in Parkinson’s disease
.
J Mov Disord
.
2020
;
13
(
3
):
185
98
.
9.
Jimenez-Shahed
J
.
Device profile of the percept PC deep brain stimulation system for the treatment of Parkinson’s disease and related disorders
.
Expert Rev Med Devices
.
2021
;
18
(
4
):
319
32
.
10.
Mohammed Ali
HA
,
Abdullah
SS
,
Faraj
M
.
An in-vitro study of electrodes impedance in deep brain stimulation
.
J Phys Conf Ser
.
2021
;
1829
(
1
):
012019
.
11.
Israeli-Korn
SD
,
Fay-Karmon
T
,
Tessler
S
,
Yahalom
G
,
Benizri
S
,
Strauss
H
, et al
.
Decreasing battery life in subthalamic deep brain stimulation for Parkinson’s disease with repeated replacements: just a matter of energy delivered
.
Brain Stimul
.
2019
;
12
(
4
):
845
50
.
12.
Sette
AL
,
Seigneuret
E
,
Reymond
F
,
Chabardes
S
,
Castrioto
A
,
Boussat
B
, et al
.
Battery longevity of neurostimulators in Parkinson disease: a historic cohort study
.
Brain Stimul
.
2019
;
12
(
4
):
851
7
.
13.
Blahak
C
,
Capelle
HH
,
Baezner
H
,
Kinfe
TM
,
Hennerici
MG
,
Krauss
JK
.
Battery lifetime in pallidal deep brain stimulation for dystonia
.
Eur J Neurol
.
2011
;
18
(
6
):
872
5
.
14.
Bin-Mahfoodh
M
,
Hamani
C
,
Sime
E
,
Lozano
AM
.
Longevity of batteries in internal pulse generators used for deep brain stimulation
.
Stereotact Funct Neurosurg
.
2003
;
80
(
1–4
):
56
60
.
15.
Anheim
M
,
Fraix
V
,
Chabardès
S
,
Krack
P
,
Benabid
AL
,
Pollak
P
.
Lifetime of Itrel II pulse generators for subthalamic nucleus stimulation in Parkinson’s disease
.
Mov Disord
.
2007
;
22
(
16
):
2436
9
.
16.
Halpern
CH
,
McGill
KR
,
Baltuch
GH
,
Jaggi
JL
.
Longevity analysis of currently available deep brain stimulation devices
.
Stereotact Funct Neurosurg
.
2011
;
89
(
1
):
1
5
.
17.
Zhang
F
,
Wang
F
,
Li
W
,
Wang
N
,
Han
C
,
Fan
S
, et al
.
Relationship between electrode position of deep brain stimulation and motor symptoms of Parkinson’s disease
.
BMC Neurol
.
2021
;
21
(
1
):
122
.
18.
Lin
Z
,
Zhang
C
,
Li
D
,
Sun
B
.
Lateralized effects of deep brain stimulation in Parkinson’s disease: evidence and controversies
.
NPJ Parkinsons Dis
.
2021
;
7
(
1
):
64
8
.
19.
Gharabaghi
A
,
Cebi
I
,
Scherer
M
,
Bookjans
P
,
Brunnett
B
,
Milosevic
L
, et al
.
Long-term effects of directional deep brain stimulation in Parkinson’s disease: a randomized clinical trial on motor and non-motor symptoms
.
medRxiv
;
2023
. [Internet].
You do not currently have access to this content.